Novavax, Inc. (NVAX)
10.46
-0.14
(-1.32%)
USD |
NASDAQ |
Oct 02, 16:00
10.44
-0.02
(-0.19%)
After-Hours: 20:00
Novavax Gross Profit Margin (Quarterly) : 77.70% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 77.70% |
| March 31, 2026 | 78.00% |
| December 31, 2025 | 82.87% |
| September 30, 2025 | 71.90% |
| June 30, 2025 | 94.05% |
| March 31, 2025 | 97.93% |
| December 31, 2024 | 40.81% |
| September 30, 2024 | 30.40% |
| June 30, 2024 | 91.33% |
| March 31, 2024 | 48.00% |
| December 31, 2023 | 48.90% |
| September 30, 2023 | 47.09% |
| June 30, 2023 | 86.98% |
| March 31, 2023 | 73.33% |
| December 31, 2022 | 49.14% |
| September 30, 2022 | 39.70% |
| June 30, 2022 | -49.41% |
| March 31, 2022 | 96.88% |
| December 31, 2021 | 98.35% |
| September 30, 2021 | 0.00% |
| June 30, 2021 | 0.00% |
| March 31, 2021 | 0.00% |
| December 31, 2020 | 0.00% |
| September 30, 2020 | 0.00% |
| June 30, 2020 | 0.00% |
| Date | Value |
|---|---|
| March 31, 2020 | 0.00% |
| December 31, 2019 | 0.00% |
| September 30, 2019 | 0.00% |
| June 30, 2019 | 0.00% |
| March 31, 2019 | 0.00% |
| December 31, 2018 | 0.00% |
| September 30, 2018 | 0.00% |
| June 30, 2018 | 0.00% |
| March 31, 2018 | 0.00% |
| December 31, 2017 | 0.00% |
| September 30, 2017 | 0.00% |
| June 30, 2017 | 0.00% |
| March 31, 2017 | 0.00% |
| December 31, 2016 | 0.00% |
| September 30, 2016 | 0.00% |
| June 30, 2016 | 0.00% |
| March 31, 2016 | 0.00% |
| December 31, 2015 | 72.05% |
| September 30, 2015 | 57.90% |
| June 30, 2015 | 80.80% |
| March 31, 2015 | 75.10% |
| December 31, 2014 | 57.81% |
| September 30, 2014 | 50.97% |
| June 30, 2014 | 38.22% |
| March 31, 2014 | 59.51% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Merck & Co., Inc. | 71.51% |
| Pfizer Inc. | 62.94% |
| Agenus, Inc. | 98.50% |
| Editas Medicine, Inc. | 96.50% |
| Recursion Pharmaceuticals, Inc. | -202.4% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -21.74% |
| Return on Invested Capital | -161.3% |
| Profit Margin (Quarterly) | -94.16% |
| Operating Margin (Quarterly) | -89.61% |
| Return on Net Operating Assets | -76.67% |